Therefore, we used a novel third-generation enzyme-linked immunosorbent assay (ELISA) for the detection of PR3-ANCAs in a large cohort of PSC patients in comparison with other autoimmune liver illnesses to investigate PR3-ANCA prevalence and association with PSC severity as well as risk scores. The gene discussed is PRTN3; the disease is pancreatic serous cystadenoma.